Position in ALXO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$54
+$24 QoQ
Shares Held
27
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 68 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Optiver Holding B.V. holds $11,140,095 across 167 Biotechnology names. ALXO ranks #155 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
10,110 | $7,382,827 | |
| 2 | LKFT |
Lakefront Biotherapeutics NV
|
26,535 | $796,050 | |
| 3 | ABVX |
Abivax S.A.
|
4,538 | $505,306 | |
| 4 | NBTX |
Nanobiotix S.A.
|
13,501 | $416,775 | |
| 5 | DBVT |
DBV Technologies S.A.
|
19,047 | $397,891 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
20,336 | $140,521 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
36,660 | $128,676 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,707 | $111,443 |
All Filings in ALXO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54 | 27 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30 | 27 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $51 | 28 | Shares | Defined | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||